IL142194A0 - Gene expressed in prostate cancer - Google Patents

Gene expressed in prostate cancer

Info

Publication number
IL142194A0
IL142194A0 IL14219499A IL14219499A IL142194A0 IL 142194 A0 IL142194 A0 IL 142194A0 IL 14219499 A IL14219499 A IL 14219499A IL 14219499 A IL14219499 A IL 14219499A IL 142194 A0 IL142194 A0 IL 142194A0
Authority
IL
Israel
Prior art keywords
prostate cancer
gene
prostate
expressed
gene expressed
Prior art date
Application number
IL14219499A
Other languages
English (en)
Original Assignee
Urogenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urogenesys Inc filed Critical Urogenesys Inc
Publication of IL142194A0 publication Critical patent/IL142194A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y10S977/91—Strengthening cell or tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y10S977/916—Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL14219499A 1998-09-30 1999-09-30 Gene expressed in prostate cancer IL142194A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10257298P 1998-09-30 1998-09-30
US14658499P 1999-07-28 1999-07-28
PCT/US1999/023005 WO2000018925A1 (en) 1998-09-30 1999-09-30 Gene expressed in prostate cancer

Publications (1)

Publication Number Publication Date
IL142194A0 true IL142194A0 (en) 2002-03-10

Family

ID=26799520

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14219499A IL142194A0 (en) 1998-09-30 1999-09-30 Gene expressed in prostate cancer
IL142194A IL142194A (en) 1998-09-30 2001-03-22 22p4f11 protein, polynucleotide encoding said protein and method for diagnosing cancer by determining the level of said protein

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142194A IL142194A (en) 1998-09-30 2001-03-22 22p4f11 protein, polynucleotide encoding said protein and method for diagnosing cancer by determining the level of said protein

Country Status (12)

Country Link
US (4) US6509458B1 (xx)
EP (2) EP1117783B1 (xx)
AT (1) ATE458049T1 (xx)
AU (2) AU764096B2 (xx)
CA (1) CA2344620A1 (xx)
CY (1) CY1110029T1 (xx)
DE (1) DE69942031D1 (xx)
DK (2) DK2182064T3 (xx)
ES (1) ES2339726T3 (xx)
IL (2) IL142194A0 (xx)
PT (1) PT1117783E (xx)
WO (1) WO2000018925A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142194A0 (en) 1998-09-30 2002-03-10 Urogenesys Inc Gene expressed in prostate cancer
AU5416700A (en) * 1999-05-20 2000-12-12 Fahri Saatcioglu Differentially expressed genes in prostate cancer
US7611892B2 (en) * 2000-03-24 2009-11-03 President And Fellows Of Harvard College Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US7189565B2 (en) * 2001-03-23 2007-03-13 Fahri Saatcioglu Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
CA2475553A1 (en) * 2002-04-03 2003-10-16 Syngenta Participations Ag Detection of wheat and barley fungal pathogens which are resistant to certain fungicides using the polymerase chain reaction
JP2004048317A (ja) * 2002-07-11 2004-02-12 Pioneer Electronic Corp ノイズ抑圧機能付きデジタル放送受信機
US7192709B2 (en) * 2004-03-15 2007-03-20 Digigenomics Co., Ltd. Methods for identification, assessment, prevention, and therapy of cancer
US8609041B2 (en) 2007-08-06 2013-12-17 Samir Mitragotri Apparatus for solubilizing tissue
US8642664B2 (en) 2007-08-06 2014-02-04 Samir Mitragotri Composition for solubilizing tissue and cells comprising N-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate and polyoxyethylene (10) cetyl ether
US8389582B2 (en) 2007-08-06 2013-03-05 Samir Mitragotri Composition for solubilizing tissue comprising 3-(decyl dimethyl ammonio) propane sulfonate and tetraethylene glycol dodecyl ether
US9814422B2 (en) 2007-08-06 2017-11-14 The Regents Of The University Of California Compositions for solubilizing cells and/or tissue
US9909098B2 (en) * 2007-08-06 2018-03-06 The Regents Of The University Of California Methods of tissue-based diagnosis
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
CN104655828B (zh) 2009-02-13 2018-04-27 加州大学评议会 基于组织的诊断的系统、方法和装置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1830195A (en) 1994-12-15 1996-07-03 Human Genome Sciences, Inc. Prostatic growth factor
US5912143A (en) * 1996-12-27 1999-06-15 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a human mage protein homolog
EP2343085B1 (en) * 1997-03-10 2014-12-10 The Regents of The University of California Antibody against prostate stem cell antigen (PSCA)
CA2294568A1 (en) * 1997-06-20 1998-12-30 Human Genome Sciences, Inc. Lyme disease vaccines
US5922546A (en) 1997-08-25 1999-07-13 Smithkline Beecham Corporation Human disintegrin metalloprotease KUZ gene
AU4839999A (en) 1998-06-29 2000-01-17 Myriad Genetics, Inc. Tmprss2 is a tumor suppressor
IL142194A0 (en) 1998-09-30 2002-03-10 Urogenesys Inc Gene expressed in prostate cancer
US7368527B2 (en) * 1999-03-12 2008-05-06 Human Genome Sciences, Inc. HADDE71 polypeptides
EP1175503A1 (en) 1999-04-09 2002-01-30 Human Genome Sciences, Inc. 49 human secreted proteins
US20020168638A1 (en) 2000-01-24 2002-11-14 Robert Schlegel Compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer

Also Published As

Publication number Publication date
DK2182064T3 (da) 2012-12-17
CA2344620A1 (en) 2000-04-06
AU764096B2 (en) 2003-08-07
DK1117783T3 (da) 2010-05-17
EP1117783B1 (en) 2010-02-17
EP2182064A1 (en) 2010-05-05
CY1110029T1 (el) 2015-01-14
IL142194A (en) 2010-12-30
DE69942031D1 (de) 2010-04-01
PT1117783E (pt) 2010-04-15
AU6285599A (en) 2000-04-17
US20100303845A1 (en) 2010-12-02
US7803916B2 (en) 2010-09-28
ES2339726T3 (es) 2010-05-24
US20090098629A1 (en) 2009-04-16
ATE458049T1 (de) 2010-03-15
AU2003259622A1 (en) 2003-11-20
US20030211520A1 (en) 2003-11-13
EP1117783A1 (en) 2001-07-25
AU2003259622B2 (en) 2006-07-06
US7432346B2 (en) 2008-10-07
US6509458B1 (en) 2003-01-21
WO2000018925A1 (en) 2000-04-06
US7968283B2 (en) 2011-06-28
EP2182064B1 (en) 2012-08-29

Similar Documents

Publication Publication Date Title
IL142194A0 (en) Gene expressed in prostate cancer
HUP0203035A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
DE60041333D1 (de) Hen prostatkrebs exprimiert wird, und deren verwendungen
WO2002046477A3 (en) Endogenous retroviruses up-regulated in prostate cancer
HK1203568A1 (en) Gene expression profiling in biopsied tumor tissues
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2001072962A3 (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
EP1515982A4 (en) METHODS AND COMPOSITIONS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
CA2100472A1 (en) Inherited and somatic mutations of apc gene in colerectal cancer of humans
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
DE69920885D1 (en) C-myc-bindendes protein "c-myc coding region determinant-binding protein (crd-bp)"
GB9824437D0 (en) Gene therapy
EP2365081A3 (en) 13 Transmembrane protein expressed in prostate cancer
AU5302599A (en) Method for diagnosing bone metastasis of malignant tumor
ATE373711T1 (de) Gewebe-spezifische protein 103p2d6, hochexprimiert in verschiedene krebsarten
AU4452900A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2002008456A3 (de) Verfahren zur identifizierung metastasierender tumorzellen
WO2001079505A3 (en) INHIBITION OF BONE TUMOR FORMATION USING ANTISENSE cDNA THERAPY
IL142311A0 (en) Methods and compositions for the diagnosis and therapy of prostate cancer
WO2000061610A3 (en) Prostate-restricted gene 30p3c8 expressed in prostate cancer
WO2002085286A3 (en) Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals
AU2002243918A1 (en) Methods for the treatment and diagnosis of prostate cancer based on p75ntr tumor
AU2003282069A8 (en) Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment